United Therapeutics (UTHR) awards RSUs and stock options to director Nilda Mesa
Rhea-AI Filing Summary
United Therapeutics Corporation director Nilda Mesa received annual non-employee director equity awards on July 22, 2026, consisting of 380 restricted stock units and 1,190 stock options. Each restricted stock unit represents the right to receive one common share upon vesting. The options carry a $527.0700 exercise price and, together with the RSUs, are scheduled to become fully vested on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Shareholders, anticipated for June 25, 2027. After these awards, Mesa directly holds 5,678 shares of United Therapeutics common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Mesa Nilda
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit F1, F2, F3, F4 | 380 | $0.00 | $0.00 |
| Grant/Award | Stock Option F2, F3 | 1,190 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 380 shares (Direct);
Stock Option — 1,190 shares (Direct);
Common Stock — 5,678 shares (Direct)
Footnotes (4)
- F1. Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- F2. Annual non-employee director award.
- F3. Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
- F4. Not applicable as restricted stock units do not have an expiration date.
Key Figures
Restricted stock units granted: 380.0000 units
Stock options granted: 1190.0000 options
Option exercise price: $527.0700 per share
+3 more
6 metrics
Restricted stock units granted
380.0000 units
Annual non-employee director RSU award on July 22, 2026
Stock options granted
1190.0000 options
Annual non-employee director stock option award on July 22, 2026
Option exercise price
$527.0700 per share
Exercise price of 1,190 stock options granted to Nilda Mesa
Option expiration date
2033-07-22
Expiration date of the director stock option award
Award vesting reference date
2027-06-25
Anticipated date of next Annual Meeting for full vesting of awards
Common shares held after awards
5678.0000 shares
Direct ownership of United Therapeutics common stock after July 22, 2026 awards
Key Terms
Restricted Stock Unit, Stock Option, Annual non-employee director award, Annual Meeting of Shareholders
4 terms
Restricted Stock Unit financial
"Each restricted stock unit represents the right to receive, following vesting, one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option financial
"Stock Option representing the right to acquire shares of common stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Annual non-employee director award financial
"Annual non-employee director award."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did United Therapeutics (UTHR) grant to director Nilda Mesa?
United Therapeutics granted director Nilda Mesa 380 restricted stock units and 1,190 stock options as annual non-employee director awards on July 22, 2026. Each RSU converts into one common share, and the options relate to an equal number of common shares at a set exercise price.
When do Nilda Mesa’s new United Therapeutics (UTHR) director awards vest?
The awards are expected to fully vest on the earlier of one year after the grant date or the date of the next Annual Meeting of Shareholders. The anticipated date of that meeting is June 25, 2027, which serves as the current vesting reference.
What is the exercise price and term of Nilda Mesa’s new United Therapeutics (UTHR) stock options?
Mesa received 1,190 stock options with an exercise price of $527.0700 per share. These options are tied to United Therapeutics common stock, vest on the same schedule as the RSUs, and are scheduled to expire on July 22, 2033 if not exercised earlier.
Were Nilda Mesa’s United Therapeutics (UTHR) equity awards made under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is not checked, indicating these equity awards were not reported as made pursuant to a Rule 10b5-1 trading plan. They are described instead as annual non-employee director awards granted on the stated grant date.